Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models

[LichGold]

INDIANAPOLIS, Sept. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the launch of Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that provides biotech companies access to drug discovery models trained on years of Lilly's research data. Lilly estimates that this first release of AI models includes proprietary data obtained at a cost of over $1 billion, representing one of the industry's most valuable datasets used to train an AI system available to biotechnology companies.

https://investor.lilly.com/news-releases/news-release-details/lilly-launches-tunelab-platform-give-biotechnology-companies

 

[Hawkeye10]

This is not charity.....to goal is to further grow Lilly.

https://www.fiercebiotech.com/biotech/lilly-catalyze360-looks-connect-emerging-biotechs-across-all-areas-exec

 

[LichGold]

Yeah I'm more about the issues with it. An ai could potentially be a god or a devil.



What should ai's first mission be?

 

[Walt]

Yeah I'm more about the issues with it. An ai could potentially be a god or a devil.


What should ai's first mission be?

AI is neither God nor devil.

The danger with AI is the potential for misalignment. While I do not see any obvious misalignment here, it is always the misalignment that you do not see that gets you in the end.